Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protective effect of high-dose atorvastatin on coronary microvascular function and cognitive function in patients undergoing coronary revascularization
2004-001672-39Phase 4Active
- Sponsor
- Dr Moya Mur
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of atorvastatin in coronary arteriosclerosis, sponsored by Dr Moya Mur. Primary endpoint: Coronary microvascular function (coronary flow reserve). Started Mar 2006; status: active.
02
Drugs
atorvastatin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2004-001672-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001672-39.